Relevium Technologies Inc
Relevium Technologies Inc. engages in the identification, evaluation, acquisition, and operation of brands and businesses in the health and wellness markets with a focus on e-commerce. The company markets dietary supplements, nutraceuticals, sports nutrition products, and cosmeceuticals primarily through its Bioganix brand portfolio online; dietary supplements under the LeefyLyfe brand; and skin … Read more
Relevium Technologies Inc (RLLVF) - Total Assets
Latest total assets as of March 2022: $3.02 Million USD
Based on the latest financial reports, Relevium Technologies Inc (RLLVF) holds total assets worth $3.02 Million USD as of March 2022.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Relevium Technologies Inc - Total Assets Trend (2013–2021)
This chart illustrates how Relevium Technologies Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Relevium Technologies Inc - Asset Composition Analysis
Current Asset Composition (June 2021)
Relevium Technologies Inc's total assets of $3.02 Million consist of 23.6% current assets and 76.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 8.5% |
| Accounts Receivable | $51.76K | 6.8% |
| Inventory | $38.79K | 5.1% |
| Property, Plant & Equipment | $5.19K | 0.7% |
| Intangible Assets | $574.80K | 75.8% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2013–2021)
This chart illustrates how Relevium Technologies Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Relevium Technologies Inc's current assets represent 23.6% of total assets in 2021, a decrease from 100.0% in 2013.
- Cash Position: Cash and equivalents constituted 8.5% of total assets in 2021, down from 33.1% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 75.0% of total assets, an increase from 0.0% in 2013.
- Asset Diversification: The largest asset category is intangible assets at 75.8% of total assets.
Relevium Technologies Inc Competitors by Total Assets
Key competitors of Relevium Technologies Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cachet Pharmaceutical Co Ltd
SHE:002462
|
China | CN¥12.68 Billion |
|
Yunnan Hongxiang Yixintang
SHE:002727
|
China | CN¥15.84 Billion |
|
Luyan Pharma Co Ltd
SHE:002788
|
China | CN¥13.04 Billion |
|
Ji Yao Holding Group Co Ltd
SHE:300108
|
China | CN¥1.43 Billion |
|
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd.
SHE:300937
|
China | CN¥1.75 Billion |
|
ShuYu Civilian Pharmacy Corp. Ltd.
SHE:301017
|
China | CN¥9.84 Billion |
|
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd
SHE:301126
|
China | CN¥6.56 Billion |
|
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A
SHE:301408
|
China | CN¥5.26 Billion |
Relevium Technologies Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Relevium Technologies Inc generates 1.20x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Relevium Technologies Inc is currently not profitable relative to its asset base.
Relevium Technologies Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.59 | 0.85 | 0.81 |
| Quick Ratio | 0.59 | 0.85 | 0.81 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-1.67 Million | $ -4.18 Million | $ -248.12K |
Relevium Technologies Inc - Advanced Valuation Insights
This section examines the relationship between Relevium Technologies Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 233.67 |
| Latest Market Cap to Assets Ratio | 2.52 |
| Asset Growth Rate (YoY) | -82.5% |
| Total Assets | $758.86K |
| Market Capitalization | $1.91 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Relevium Technologies Inc's assets at a significant premium ( 2.52x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Relevium Technologies Inc's assets decreased by 82.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Relevium Technologies Inc (2013–2021)
The table below shows the annual total assets of Relevium Technologies Inc from 2013 to 2021.
| Year | Total Assets | Change |
|---|---|---|
| 2021-06-30 | $758.86K | -82.49% |
| 2020-06-30 | $4.33 Million | -49.37% |
| 2019-06-30 | $8.56 Million | +31.32% |
| 2018-06-30 | $6.52 Million | +18.99% |
| 2017-06-30 | $5.48 Million | +608.91% |
| 2016-06-30 | $772.84K | +101.15% |
| 2015-06-30 | $384.20K | -15.29% |
| 2014-06-30 | $453.53K | -27.79% |
| 2013-06-30 | $628.04K | -- |